Back to Cancer Australia's website

Cancer Australia

Select a guideline

Recommendations for Aromatase inhibitors as adjuvant endocrine therapy

Details of trials or studies

Table 1: Trial details
TRIAL FULL NAME AROMATASE INHIBITOR MEDIAN FOLLOW-UP REFERENCE
ATAC Arimidex, Tamoxifen Alone or in Combination Anastrozole 68 months 2, 9-12
BIG 1-98 Breast International Group 1-98 Letrozole 26 months 3
IES Intergroup Exemestane Study Exemestane 31 months 4
ITA Italian Tamoxifen Arimidex Anastrozole 52 months 5
ABCSG/ARNO Austrian Breast Cancer Study Group/Arimidex-Nolvadex Anastrozole 26 months 6
MA.17 Late Letrozole Trial Letrozole 28 months 7, 13, 14

Published using CeCC Docbook Manager